Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adipocytes: active facilitators in epithelial ovarian cancer progression?
Lan Dai, Keqi Song, Wen Di
Journal of Ovarian Research (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Assessment of causal effects of visceral adipose tissue on risk of cancers: a Mendelian randomization study
Yao Lu, Haibo Tang, Peiyuan Huang, et al.
International Journal of Epidemiology (2022) Vol. 51, Iss. 4, pp. 1204-1218
Open Access | Times Cited: 38
Extracellular vesicles as mediators of cell-cell communication in ovarian cancer and beyond – A lipids focus
Shikha Rani, Andrew Lai, Soumyalekshmi Nair, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 73, pp. 52-68
Open Access | Times Cited: 22
Combination of Nanomaterials in Cell-Based Drug Delivery Systems for Cancer Treatment
Lu Tang, Shun He, Yue Yin, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1888-1888
Open Access | Times Cited: 44
Targeting lipid metabolism in the treatment of ovarian cancer
Saliha Chaudhry, Stefani N. Thomas, Glenn Simmons
Oncotarget (2022) Vol. 13, Iss. 1, pp. 768-783
Open Access | Times Cited: 29
Health Complications of Obesity
Michele Yuen
Gastroenterology Clinics of North America (2023) Vol. 52, Iss. 2, pp. 363-380
Closed Access | Times Cited: 22
Anti-tumor immune potentiation targets-engineered nanobiotechnologies: Design principles and applications
Rong Jiao, Xia Lin, Qian Zhang, et al.
Progress in Materials Science (2023) Vol. 142, pp. 101230-101230
Closed Access | Times Cited: 20
Performance of computational algorithms to deconvolve heterogeneous bulk ovarian tumor tissue depends on experimental factors
Ariel A. Hippen, Dalia K. Omran, Lukas M. Weber, et al.
Genome biology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 19
Metastatic Voyage of Ovarian Cancer Cells in Ascites with the Assistance of Various Cellular Components
Kaname Uno, Shohei Iyoshi, Masato Yoshihara, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4383-4383
Open Access | Times Cited: 25
Polymeric Hydrogels for In Vitro 3D Ovarian Cancer Modeling
Simona Braccini, Chiara Tacchini, Emo Chiellini, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3265-3265
Open Access | Times Cited: 23
Etiopathogenesis of ovarian cancer. An inflamm-aging entity?
Manuel Sánchez‐Prieto, Rafael Sánchez-Borrego, Daniel Maria Lubián-López, et al.
Gynecologic Oncology Reports (2022) Vol. 42, pp. 101018-101018
Open Access | Times Cited: 20
The impact of obesity and adipokines on breast and gynecologic malignancies
Surabhi Tewari, Roberto Vargas, Ofer Reizes
Annals of the New York Academy of Sciences (2022) Vol. 1518, Iss. 1, pp. 131-150
Open Access | Times Cited: 20
IL-15/IL-15Rα-secreting bioengineered adipocytes reactivate NK/CD8+ T cells in ovarian and colon cancer ascites
Yuanxin Zhang, Tong Li, A P Liu, et al.
International Journal of Biological Macromolecules (2025), pp. 140559-140559
Closed Access
Molecular characteristics and tumorigenicity of ascites‐derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer
Yi� Ding, Vera Labitzky, Karen Legler, et al.
Molecular Oncology (2021) Vol. 15, Iss. 12, pp. 3578-3595
Open Access | Times Cited: 25
High visceral fat-to-muscle ratio is an independent factor that predicts worse overall survival in patients with primary epithelial ovarian, fallopian tube, and peritoneal cancer
Sooji Ham, Jin Hwa Choi, Soo Gui Shin, et al.
Journal of Ovarian Research (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 9
The multicellular signalling network of ovarian cancer metastases
Leah Sommerfeld, Florian Finkernagel, Julia M. Jansen, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 11
Open Access | Times Cited: 19
Personalized models of heterogeneous 3D epithelial tumor microenvironments: Ovarian cancer as a model
Eric N. Horst, Michael E. Bregenzer, Pooja Mehta, et al.
Acta Biomaterialia (2021) Vol. 132, pp. 401-420
Open Access | Times Cited: 18
Irisin/FNDC5 inhibits the epithelial–mesenchymal transition of epithelial ovarian cancer cells via the PI3K/Akt pathway
Ting Zhu, Weina Zhang, Yumin Zhang, et al.
Archives of Gynecology and Obstetrics (2022) Vol. 306, Iss. 3, pp. 841-850
Closed Access | Times Cited: 13
Obesity-Associated ECM Remodeling in Cancer Progression
Junyan Li, Ren Xu
Cancers (2022) Vol. 14, Iss. 22, pp. 5684-5684
Open Access | Times Cited: 12
Early adulthood overweight and obesity and risk of premenopausal ovarian cancer, and premenopausal breast cancer including receptor status: prospective cohort study of nearly 500,000 Danish women
Aivara Urbutė, Kirsten Frederiksen, Susanne K. Kjær
Annals of Epidemiology (2022) Vol. 70, pp. 61-67
Closed Access | Times Cited: 11
A Novel Synthesized Cyclohexane-Hydroxytyrosol Derivative Suppresses Ovarian Cancer Cell Growth Through Inducing Reactive Oxidative Species and Blocking Autophagic Flux
Guanfei Zhang, Min Wang, Yilin Gao, et al.
Antioxidants and Redox Signaling (2024) Vol. 41, Iss. 7-9, pp. 430-461
Closed Access | Times Cited: 2
Research progress on anti-ovarian cancer mechanism of miRNA regulating tumor microenvironment
MingHua Cui, YueHui Liu, Cheng Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Obesity in children and adolescents and the risk of ovarian cancer: A systematic review and dose‒response meta-analysis
Nan Ding, Junyi Zhan, Youjin Shi, et al.
PLoS ONE (2022) Vol. 17, Iss. 12, pp. e0278050-e0278050
Open Access | Times Cited: 10
Fatty acid transport protein inhibition sensitizes breast and ovarian cancers to oncolytic virus therapy via lipid modulation of the tumor microenvironment
Abera Surendran, Monire Jamalkhah, Joanna Poutou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Insights into the tumor-stromal-immune cell metabolism cross talk in ovarian cancer
Priscilla W. Tang, Leonard Frisbie, Nadine Hempel, et al.
AJP Cell Physiology (2023) Vol. 325, Iss. 3, pp. C731-C749
Closed Access | Times Cited: 5
Metabolic cross-talk between ovarian cancer and the tumor microenvironment—providing potential targets for cancer therapy
Yi Lin, Xiao Liang, Xijie Zhang, et al.
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 4
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top